Nomura Asset Management Co. Ltd. Has $3.83 Million Stock Holdings in Solventum Corporation $SOLV

Nomura Asset Management Co. Ltd. boosted its holdings in Solventum Corporation (NYSE:SOLV) by 12.0% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 50,516 shares of the company’s stock after acquiring an additional 5,420 shares during the period. Nomura Asset Management Co. Ltd.’s holdings in Solventum were worth $3,831,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors also recently modified their holdings of the company. Nisa Investment Advisors LLC grew its position in Solventum by 0.6% in the second quarter. Nisa Investment Advisors LLC now owns 33,974 shares of the company’s stock valued at $2,577,000 after acquiring an additional 210 shares during the last quarter. South Dakota Investment Council grew its position in Solventum by 3.6% in the 2nd quarter. South Dakota Investment Council now owns 255,625 shares of the company’s stock valued at $19,387,000 after purchasing an additional 8,960 shares during the period. Chelsea Counsel Co. grew its holdings in Solventum by 720.7% during the second quarter. Chelsea Counsel Co. now owns 10,595 shares of the company’s stock worth $804,000 after buying an additional 9,304 shares in the last quarter. ST Germain D J Co. Inc. lifted its position in shares of Solventum by 84.6% during the 2nd quarter. ST Germain D J Co. Inc. now owns 825 shares of the company’s stock worth $63,000 after buying an additional 378 shares in the last quarter. Finally, Terril Brothers Inc. grew its position in Solventum by 15.3% during the second quarter. Terril Brothers Inc. now owns 96,516 shares of the company’s stock valued at $7,320,000 after buying an additional 12,800 shares during the period.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on SOLV. Weiss Ratings reissued a “hold (c)” rating on shares of Solventum in a report on Thursday, October 30th. Wall Street Zen cut Solventum from a “buy” rating to a “hold” rating in a research note on Saturday, November 15th. Zacks Research raised shares of Solventum from a “hold” rating to a “strong-buy” rating in a research note on Monday, September 15th. Jefferies Financial Group initiated coverage on Solventum in a research report on Thursday, September 11th. They issued a “hold” rating and a $80.00 price target on the stock. Finally, UBS Group restated a “neutral” rating on shares of Solventum in a research note on Friday. One investment analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $85.56.

Solventum Trading Up 4.3%

Solventum stock opened at $82.93 on Friday. The stock has a market cap of $14.38 billion, a P/E ratio of 9.55, a PEG ratio of 8.39 and a beta of 0.48. The firm’s 50 day moving average price is $72.68 and its 200-day moving average price is $73.08. The company has a debt-to-equity ratio of 1.03, a current ratio of 1.50 and a quick ratio of 1.14. Solventum Corporation has a 1 year low of $60.70 and a 1 year high of $85.92.

Solventum (NYSE:SOLV) last issued its quarterly earnings data on Thursday, November 6th. The company reported $1.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.43 by $0.07. The business had revenue of $2.10 billion for the quarter, compared to analysts’ expectations of $2.05 billion. Solventum had a return on equity of 28.01% and a net margin of 18.13%.The company’s revenue for the quarter was up .7% on a year-over-year basis. During the same period in the prior year, the firm earned $1.64 EPS. Solventum has set its FY 2025 guidance at 5.980-6.080 EPS. On average, equities analysts predict that Solventum Corporation will post 6.58 earnings per share for the current fiscal year.

Solventum declared that its Board of Directors has approved a stock repurchase plan on Thursday, November 20th that permits the company to buyback $1.00 billion in outstanding shares. This buyback authorization permits the company to purchase up to 7.5% of its stock through open market purchases. Stock buyback plans are generally a sign that the company’s management believes its stock is undervalued.

Solventum Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.